Physician
Hematology
Dr. Jonathan W. Riess, MD
|
|
Give Review
Jonathan W. Riess, MD practices Hematology. He went to Rutgers Robert Wood Johnson Medical School. Rutgers Robert Wood Johnson Medical School is ranked 74 in research and 67 in primary care medicine He has 1 awards "CMS Meaningful Use Stage 1 Certification". Jonathan W. Riess, MD is a published doctor. He published 15 publications, including: 'New and emerging developments in extensive-stage small cell lung cancer therapeutics.' He is registered with Medicare and accepts Medicare payments.
Publications
- New and emerging developments in extensive-stage small cell lung Cancer therapeutics.
- P1.06Phase I study of the combination of alisertib (MLN8237) and gemcitabine in advanced solid Tumors.
- GLI1, CTNNB1 and NOTCH1 protein expression in a thymic epithelial malignancy tissue microarray.
- Pemetrexed in patients with thymic Malignancies previously treated with chemotherapy.
- Diffuse High Intensity PD-L1 Staining in Thymic Epithelial Tumors.
- Left behind? Drug discovery in extensive-stage small-cell lung Cancer.
- Immune correlates of talactoferrin alfa in biopsied tumor of relapsed/refractory metastatic non-small cell lung Cancer patients.
- A phase II multicentre study of ziv-aflibercept in combination with cisplatin and pemetrexed in patients with previously untreated advanced/metastatic non-squamous non...
- Acquired Resistance to Targeted Therapies Against Oncogene-Driven Non-Small-Cell Lung Cancer: Approach to Subtyping Progressive Disease and Clinical Implications.
- A Drug Repositioning Approach Identifies Tricyclic Antidepressants as Inhibitors of Small Cell Lung Cancer and Other Neuroendocrine Tumors.
- A patient with anaplastic lymphoma kinase-positive non-small cell lung Cancer with development of leptomeningeal carcinomatosis while on targeted treatment with crizot...
- A Case Series of NSCLC Patients with Different Molecular Characteristics and Choroidal Metastases: Improvement in Vision with Treatment Including Pemetrexed and Bevaci...
- Targeting fibroblast growth factor receptor and discoidin domain receptor 2 in non-small-cell lung Cancer.
- Metastatic non-small cell lung Cancer management: novel targets and recent clinical advances.
Schools
University of Medicine And Dentistry of New Jersey Robert Wood Johnson Medical School
Conditions Treated
- Breast Cancer
- ENT Cancer
- Laryngeal Cancer
- Lung Cancer
- View All
Doctors Specialties
- Hematology
- Medical Oncology
- Oncology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
Education
-
Stanford University -
UCSF -
Rutgers Robert Wood Johnson Medical School
Hospital
-
University of California, Davis Medical Center
Drug Facts
| NPI NUMBER | 1619132461 | |
| NPPES Provider LastName | RIESS | |
| NPPES Provider FirstName | JONATHAN | |
| NPPES Provider ZIPCode | 958172229 | |
| NPPES Provider State | CA | |
| Specialty Description | Hematology/Oncology | |
| Total Claim Count | 101.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1619132461 |
| Last Name Of The Provider | RIESS |
| First Name Of The Provider | JONATHAN |
| View All |
Similar Doctors
|
|
Dr. Denis M. Dwyre, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jeanna L. Welborn, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Shahzad A. Siddique, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michael S. Tanaka Jr., MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Karen L. Kelly, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Derick H. Lau, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Hanne M. Jensen, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Edward C. Larkin, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Benjamin K. Tomlinson, MD |